Hu Jianzhang, Zhang Jingjin, Li Yanling, Han Xiaoli, Zheng Weidong, Yang Juan, Xu Guoxing
The Eye Center of the First Affiliated Hospital of Fujian Medical University, Fujian Eye Institute, 20 Chazhong Road, Fuzhou 350005, China.
J Ophthalmol. 2016;2016:3436415. doi: 10.1155/2016/3436415. Epub 2016 Sep 19.
. To evaluate the efficacy of a combination of intrastromal and intracameral injections of amphotericin B in the treatment of severe recalcitrant fungal keratitis. . Patients with severe fungal keratitis who were resistant to conventional antifungal medical treatments and needed potential surgical intervention were recruited at the First Affiliated Hospital of Fujian Medical University between January 2012 and July 2013. The patients were treated with a combination of intrastromal and intracameral injections of amphotericin B (25 g/mL and 50 g/mL, resp.). Selectively repeated injections were performed as necessary. The efficacy, complications, and outcome were evaluated. . Nine patients (9 eyes) were involved in this study. All 9 cases responded favorably, and the clinical appearance of serious corneal damage and intraocular extension was resolved after the treatment. Four eyes required only 1 injection, and 5 eyes required repeated injections. Seven corneal ulcers healed with leucoma, and 2 healed with adherent leucoma. All of our cases had a marked increase in the anterior chamber reaction and pain immediately after the injection. There was no obvious clinical evidence of corneal or lenticular toxicity in any patient. . A combination of intrastromal and intracameral injections of amphotericin B may be safe and effective for the treatment of severe fungal keratitis that is resistant to conventional therapy.
评估基质内注射与前房内注射两性霉素B联合治疗重度顽固性真菌性角膜炎的疗效。2012年1月至2013年7月期间,福建医科大学附属第一医院招募了对传统抗真菌药物治疗耐药且需要潜在手术干预的重度真菌性角膜炎患者。患者接受基质内注射与前房内注射两性霉素B联合治疗(分别为25μg/mL和50μg/mL)。必要时进行选择性重复注射。评估疗效、并发症及治疗结果。本研究纳入9例患者(9只眼)。所有9例患者反应良好,治疗后严重角膜损伤及眼内蔓延的临床表现均得到缓解。4只眼仅需注射1次,5只眼需重复注射。7例角膜溃疡愈合后形成白斑,2例愈合后形成粘连性白斑。所有病例在注射后前房反应和疼痛均明显加重。所有患者均无明显的角膜或晶状体毒性临床证据。基质内注射与前房内注射两性霉素B联合治疗对传统治疗耐药的重度真菌性角膜炎可能是安全有效的。